ECSP056060A - Nuevo medicamento - Google Patents

Nuevo medicamento

Info

Publication number
ECSP056060A
ECSP056060A EC2005006060A ECSP056060A ECSP056060A EC SP056060 A ECSP056060 A EC SP056060A EC 2005006060 A EC2005006060 A EC 2005006060A EC SP056060 A ECSP056060 A EC SP056060A EC SP056060 A ECSP056060 A EC SP056060A
Authority
EC
Ecuador
Prior art keywords
medicinal product
new medicinal
zero
new
8alkenyl
Prior art date
Application number
EC2005006060A
Other languages
English (en)
Inventor
Jessica Mann
Original Assignee
Speedel Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Pharma Ag filed Critical Speedel Pharma Ag
Publication of ECSP056060A publication Critical patent/ECSP056060A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a compuestos y procedimientos de la fórmula (I) en donde R1 es piridilo o tiazolilo, cualquiera de los cuales puede opcionalmente estar substituido con C1-8alquilo o C2-8alquenilo; y a) R2 es metoxi y n es cero o uno; o b) R2 es cloro y n es cero y sus sales farmacéuticamente aceptables, para reducir o controlar proteinuria, en particular para el tratamiento de nefropatía diabética, lo cual debe ser entendido como la aplicación práctica del producto, y no la reivindicación del método de tratamiento como tal.
EC2005006060A 2003-03-06 2005-09-29 Nuevo medicamento ECSP056060A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03100549A EP1454625A1 (en) 2003-03-06 2003-03-06 Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies

Publications (1)

Publication Number Publication Date
ECSP056060A true ECSP056060A (es) 2006-01-27

Family

ID=32799012

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006060A ECSP056060A (es) 2003-03-06 2005-09-29 Nuevo medicamento

Country Status (26)

Country Link
US (2) US20060094731A1 (es)
EP (2) EP1454625A1 (es)
JP (1) JP4737686B2 (es)
KR (1) KR101099189B1 (es)
CN (1) CN100453081C (es)
AT (1) ATE395063T1 (es)
AU (2) AU2004216858B2 (es)
BR (1) BRPI0408082A (es)
CA (1) CA2517930C (es)
CY (1) CY1108241T1 (es)
DE (1) DE602004013734D1 (es)
DK (1) DK1601361T3 (es)
EC (1) ECSP056060A (es)
ES (1) ES2305737T3 (es)
HR (1) HRP20050860A2 (es)
IL (1) IL170626A (es)
MX (1) MXPA05009478A (es)
NO (1) NO20054148L (es)
NZ (1) NZ542155A (es)
PL (1) PL1601361T3 (es)
PT (1) PT1601361E (es)
RS (1) RS20050683A (es)
SI (1) SI1601361T1 (es)
UA (1) UA82087C2 (es)
WO (1) WO2004078104A2 (es)
ZA (1) ZA200507122B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1595880A1 (en) * 2004-05-13 2005-11-16 Speedel Pharma AG Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
BRPI0615794A2 (pt) * 2005-09-12 2011-05-24 Speedel Pharma Ag piridilsulfonamidil-pirimidinas para a prevenção de falha de enxerto de vaso sangüìneo
RU2635460C2 (ru) 2010-06-17 2017-11-13 Нитто Денко Корпорейшн Средство для лечения фиброза почек
CN109260164A (zh) * 2018-10-07 2019-01-25 威海贯标信息科技有限公司 一种阿伏生坦片剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507086A (pt) * 1994-03-17 1997-09-16 Ciba Geigy Ag Tratamento de nefroterapia diabética com valsartan
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
ES2195002T3 (es) * 1995-08-02 2003-12-01 Smithkline Beecham Corp Antagonistas de los receptores de la endotelina.
US6417360B1 (en) * 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
AU2001263850A1 (en) * 2000-04-20 2001-11-07 Actelion Pharmaceuticals Ltd Pyrimidine-sulfonamides having endothelin-antagonist activity

Also Published As

Publication number Publication date
WO2004078104A3 (en) 2004-10-28
DK1601361T3 (da) 2008-08-25
KR101099189B1 (ko) 2011-12-27
EP1454625A1 (en) 2004-09-08
ZA200507122B (en) 2006-05-31
CA2517930A1 (en) 2004-09-16
EP1601361B1 (en) 2008-05-14
CN1756552A (zh) 2006-04-05
US20090005404A1 (en) 2009-01-01
AU2009225323A1 (en) 2009-11-05
AU2004216858B2 (en) 2009-07-16
PL1601361T3 (pl) 2008-10-31
CN100453081C (zh) 2009-01-21
US20060094731A1 (en) 2006-05-04
RS20050683A (sr) 2007-11-15
IL170626A (en) 2010-05-31
PT1601361E (pt) 2008-07-29
EP1601361A2 (en) 2005-12-07
SI1601361T1 (sl) 2008-10-31
ES2305737T3 (es) 2008-11-01
MXPA05009478A (es) 2005-10-18
HRP20050860A2 (en) 2005-10-31
ATE395063T1 (de) 2008-05-15
BRPI0408082A (pt) 2006-02-14
DE602004013734D1 (de) 2008-06-26
AU2004216858A1 (en) 2004-09-16
JP2006519817A (ja) 2006-08-31
NZ542155A (en) 2008-09-26
HK1083761A1 (en) 2006-07-14
CA2517930C (en) 2011-04-26
KR20050106083A (ko) 2005-11-08
NO20054148L (no) 2005-09-06
WO2004078104A2 (en) 2004-09-16
CY1108241T1 (el) 2013-09-04
UA82087C2 (uk) 2008-03-11
AU2009225323B2 (en) 2011-11-24
JP4737686B2 (ja) 2011-08-03

Similar Documents

Publication Publication Date Title
DE60330757D1 (de) Verwendung von pyridylamiden als angiogenesehemmer
TW200745069A (en) Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and its use
NO20052796L (no) Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
TW200745070A (en) Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and their use
ATE372767T1 (de) Dpp-iv-hemmer
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
AR045959A1 (es) Derivados de pirazolo- e imidazo-pirimidina
NO20082118L (no) Heterocykliske CETP-inhibitorer
BR0307894A (pt) Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos
NO20052908D0 (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
NO20070974L (no) Substituerte N-acyl-2-aminotiazoler
GB0412314D0 (en) Compounds
CY1108241T1 (el) Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
DE602005010421D1 (de) Neue Cysteine Protease Hemmers und ihre therapeutische Anwendungen
BRPI0607214A2 (pt) derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
TW200728291A (en) Amide derivatives
ZA200800999B (en) Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
ATE338046T1 (de) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
ATE538108T1 (de) Thiazolhydrazide und deren verwendung zur behandlung von neurodegenerativen krankheiten
DE60214558D1 (de) 2-(AMINOMETHYL)TETRAHYDRO-9-OXA-1,3-DIAZACYCLOPENTAcAÜNAPHTHALINYLDERIVATE MIT ANTIPSYCHOTISCHER WIRKUNG
TH76971A (th) อนุพันธ์ไตรไซคลิกที่ถูกหลอม
ZA200710662B (en) 1-[2', 3'-dideoxy-3' C-(hydroxymethyl)-beta-d-erythropentofuranosyl] cytosine derivatives as HIV inhibitors